Ginkgo Bioworks CEO Jason Kelly receives 81,484 shares as restricted stock units vest
DNA•Ginkgo Bioworks CEO Jason R. Kelly converted 81,484 restricted stock units into Class A common stock on October 16, 2026. The awards had 18,564 and 283,677 restricted stock units remaining after the conversions.
1. Share award conversion
Jason R. Kelly converted 81,484 restricted stock units into Ginkgo Bioworks Class A common stock on October 16, 2026. The two awards had 18,564 and 283,677 restricted stock units remaining after the conversions.




